ClinicalTrials.Veeva

Menu

Patient Morbidity After Palatal Free Gingival Grafts With or Without PRF Membranes Coverage

A

Azienda Ospedaliera San Paolo

Status

Completed

Conditions

Postoperative Complications
Postoperative Pain
Gingival Recession

Treatments

Drug: hemostatic agents with oxidized and regenerated cellulosa
Biological: Platelet rich fibrin ( PRF)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study evaluates postoperative morbidity of patients that undergo free gingival graft harvesting from palate with or without use of autogenous PRF (Platelet Rich Fibrin) membranes to cover the donor site.In the Test Group venous blood sampling was done in order to prepare PRF membranes used to cover the donor site, whereas in Control Group hemostatic agents with oxidized and regenerated cellulosa were used.

Enrollment

42 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • FMPS (Full Mouth Plaque Score) and FMBS (Full Mouth Bleeding Score) < 20%,
  • presence of two adjacent Miller's Class I and II recession defects on natural teeth (≥ 2mm in depth);

Exclusion criteria

  • contraindications for periodontal surgery
  • taking medications or having diseases known to interfere with periodontal tissue health or healing and coagulation.
  • smoking more than 10 cigarettes a day
  • Gingival recessions on molar teeth were excluded.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

42 participants in 2 patient groups

Test Group
Experimental group
Description:
In the Test Group venous blood sampling was done in order to prepare PRF membranes used to cover the donor site of the connective tissue graft.
Treatment:
Biological: Platelet rich fibrin ( PRF)
Control Group
Active Comparator group
Description:
In Control Group hemostatic agents with oxidized and regenerated cellulosa were used to cover the donor site.
Treatment:
Drug: hemostatic agents with oxidized and regenerated cellulosa

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems